Covington & Burling LLP advised Indivior, while Latham & Watkins LLP represented Opiant in the transaction. Opiant Pharmaceuticals Inc. (NASDAQ: OPNT) has entered into a definitive...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here